R. A. Hrytsyk

R. A. Hrytsyk

Auto-generated profile, based on publicly available information

R. A. Hrytsyk

Ivano-Frankivsk National Medical University, Department of Oncology, Ivano-Frankivsk, Ukraine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
YHYurii Hrytsyk
Yurii Hrytsyk
Oleh KoshovyiOleh Koshovyi
Oleh Koshovyi
RHRoman Hrytsyk
Roman Hrytsyk
Ain RaalAin Raal
Ain Raal
S. canadensis L. and S. virgaurea L. are the most common species of Solidago L. in Europe and with a long tradition of use in medicine for various therapeutic purposes: diseases of the urinary tract, gastrointestinal tract, diabetes, allergies and antiseptic purposes. Therefore, the research of species of the Solidago genus, which have a rich content of natural BACs, and the development of new effective medicinal products of plant origin are relevant. The aim. The method of work is the phytochemical and pharmacological study of extracts of the Canadian goldenrod herb, obtained by ethanol solutions of various concentrations, for the innovative perspective of creating new medicines based on them with antimicrobial, anti-inflammatory and hepatoprotective activity. Materials and methods. The objects of the study were extracts of herb from Canadian goldenrod, obtained using purified water, 40 %, 70 % and 90 % ethanol. Phytochemical study of the extracts was performed by TLC and spectrophotometry. Study of acute toxicity, antimicrobial, anti-inflammatory and hepatoprotective activity of extracts was carried out according to standard methods. Research results. A study of the phytochemical composition and pharmacological activity of extracts of herb from Canadian goldenrod obtained with different solvents. It was established that extracts of herb from Canadian goldenrod show anti-inflammatory activity. The most pronounced antiexudative activity is shown by the extract of the Canadian goldenrod herb (extractant - 40 % ethanol), reducing the degree of swelling by 24.77 %. Herb extracts from from Canadian goldenrod in acute toxic liver damage show moderate hepatoprotective activity, which is somewhat inferior to the comparative drug "Silibor". A more intense and effective effect on the hepatobiliary system was shown by the extract of the Canadian goldenrod herb (extractant - 40 % ethanol). Conclusions. The perspective of creation based on herb of Canadian goldenrod new drugs with hepatoprotective activity. The most promising substance turned out to be an extract of herb from Canadian goldenrod obtained with a 40 % ethanol solution.

29 March 2026 in Art of Medicine
Verified
Journal Article
Open access
PDF file
DVD. A. Veremey
D. A. Veremey
SBS. M. Balaka
S. M. Balaka
RHR. A. Hrytsyk
R. A. Hrytsyk
IDI. A. Dmytrenko
I. A. Dmytrenko
AKA. Ye. Kryzhanivska
A. Ye. Kryzhanivska
Ovarian tumors encompass several pathohistological formations, with epithelial ovarian cancer accounting for the majority of malignant ovarian tumors (about 90%). Ovarian cancer (OC) is the seventh most common malignancy diagnosed in women, the eighth leading cause of cancer mortality worldwide, and the most prevalent cause of death among all gynecologic cancers. According to the American Cancer Society, approximately 21,750 new cases of OC were reported in the United States in 2020, with 13,940 deaths attributed to the disease, making OC the fifth leading cause of cancer mortality among women in the country. Despite recent advancements in technology enabling more accurate radiological and laboratory diagnostic tests, about 60% of OC cases are diagnosed at a late stage. Prognosis and survival rates for OC significantly depend on the stage of the disease at the time of detection. The 5-year survival rate is approximately 49%, though it is higher in some patients with early-stage disease and certain histological subtypes. Approximately half of the patients have distant manifestations of the disease; however, some rare subtypes, such as clear cell and endometrioid cancer, are more likely to be diagnosed at early stages. Most types of ovarian cancer are diagnosed after pathohistological analysis of a biopsy or surgical sample, which can occur preoperatively, intraoperatively, or postoperatively. Fine-needle biopsy is recommended for patients who are not candidates for primary cytoreductive surgery, such as those with extensive peritoneal carcinomatosis, elderly patients, or patients with comorbidities (according to NCCN guidelines, 2024). Thus, identifying new diagnostic and therapeutic methods for clinical application has become a major focus of OC research. Objective. To investigate the safety and efficacy of trephine biopsy as a method for collecting tumor tissue samples to verify the neoplastic process in suspected ovarian cancer cases. Materials and Methods. A retrospective analysis of 21 clinical cases of trephine biopsies performed on ovarian cancer patients from April 2022 to February 2024 at the "PKOZ IF OR" facility was conducted. Patients with stage IA-IIIA ovarian cancer did not participate in this study, as histological verification was not performed on these patients in a neoadjuvant setting. Results. The results of trephine biopsies performed under ultrasound guidance for cancer were analyzed, including the duration of the procedure and the outcomes of the pathohistological conclusions. According to the pathohistological examination of the biopsy samples, 20 patients (95.3%) were verified to have some form of malignant ovarian tumor. In 1 patient (4.7%), the biopsy was uninformative. Diagnostic laparoscopy was performed on 3 patients (14.2%) prior to trephine biopsy, but histological confirmation of the diagnosis "ovarian cancer" was not obtained. Histological examination of the samples obtained during trephine biopsy verified malignant ovarian tumors in all these patients. Conclusions. Trephine biopsy is an effective and safe method for collecting tumor samples for pathomorphological verification of the neoplastic process in malignant ovarian tumors, provided that the indications and contraindications for the procedure are followed and timely correction of concomitant pathology is performed. This method is associated with a low complication rate, minimal operational trauma, short hospital stay, and the possibility of performing the diagnostic intervention on an outpatient basis. Рак яйників (РЯ) є сьомою за поширеністю злоякісною пухлиною, діагностованою в жінок, восьмою провідною причиною смертності від раку в усьому світі та найпоширенішою причиною смерті серед усіх онкогінекологічних захворювань. За даними Американського онкологічного товариства, у 2020 році в США було зареєстровано приблизно 21 750 нових випадків РЯ, з яких 13 940 смертей були пов’язані з цією хворобою, що робить РЯ п’ятою провідною причиною смертності від раку серед жінок у країні. Незважаючи на те, що останній прогрес у технології дозволив проводити більш точні радіологічні та лабораторні діагностичні тести, приблизно 60% випадків РЯ діагностують на пізній стадії. Прогностичні показники та виживаність при РЯ суттєво залежать від стадії захворювання на момент виявлення. Таким чином, визначення нових діагностичних і терапевтичних методів для клінічного застосування постало основним напрямком досліджень РЯ. Мета. Вивчити безпечність і ефективність трепан-біопсії як методу набору зразків пухлинної тканини для верифікації неопроцесу при підозрі на рак яйника. Матеріали та методи. Ретроспективно проведено аналіз 21 клінічного випадку трепан-біопсій у пацієнток із раком яйника з квітня 2022 року до лютого 2024 року на базі КНП «ПКОЦ ІФ ОР». Пацієнтки з раком яйників у стадії ІА-ІІІА не взяли участь у вказаному дослідженні,...

14 January 2023 in Art of Medicine
Verified
Journal Article
Open access
PDF file
RHR. A. Hrytsyk
R. A. Hrytsyk
OSO. A. Struk
O. A. Struk
LGLyubov Grytsyk
Lyubov Grytsyk
ADA. M. Dmytriv
A. M. Dmytriv
At the present stage of the development of science, it remains relevant to create new medicines of plant origin with the use of extracts as active substances and improvement of the composition and technology of existing ones. The article aimed to highlight the main stages of preclinical studies of herbal extracts of Artemisia species to establish their pharmacological activity, preclinical safety profile, and prospects for further research in developing a medicinal product. As a result of the research conducted using the method of generalization and systematic analysis, we identified the main stages of pharmacological research of plant extracts as medicinal substances using the example of Artemisia absinthium L. and Artemisia vulgaris L. extracts. Identifying the main stages of pharmacological research of plant extracts is necessary to establish the preclinical profile of the substance's safety, pharmacological effectiveness, and prospects for further study in the development of the medicinal product. In the first stage, a toxico-pharmacological study of the extracts is carried out, which includes the study of acute toxicity of the еxtracts. It was established that the intragastric administration of extracts of Artemisia absinthium L. and Artemisia vulgaris L. at a dose of 6000 mg/kg does not lead to the death of animals, which indicates the absence of toxic effects of the extracts in this dose, and characterizes them as practically non-toxic (toxicity class V, LD50 > 5000 mg/kg). At the second stage of pharmacological research, the anti-inflammatory activity of Artemisia absinthium L. and Artemisia vulgaris L. extracts was studied (on models of formalin, carrageenan, and zymosan edema). It was established that the sections of Artemisia absinthium L. and Artemisia vulgaris L. showed a pronounced anti-exudative effect throughout the experiment. At the third research stage, a study of specific pharmacological activity – hepatoprotective (antioxidant) training was activity. It was found that extracts of Artemisia species exhibit hepatoprotective activity in acute toxic liver damage, which leads to a decrease in the intensity of the lipid peroxidation process and a reduction in the harmful effect of tetrachloromethane, bringing the biochemical indicators of blood and liver homogenate of animals to the level of intact animals. The results of the research show that the extract of the herb Artemisia absinthium L. at a dose of 25 mg/kg of the animal's body weight showed a more intense and more effective effect in acute hepatitis compared to the extract of the herb Artemisia vulgaris L. The extract of the herb Artemisia absinthium L. are not inferior to the hepatoprotective effect of the comparative drug "Silibor". So, we established a general design of pharmacological research, which included the following stages: I stage. Study of the harmlessness of extracts - study of acute toxicity. II stage. Study of pharmacological activity of extracts - anti-inflammatory activity. III stage. Research of specific pharmacological activity – hepatoprotective (antioxidative) activity. Thus, a properly planned preclinical study showed the absence of toxic effects of Artemisia absinthium L. and Artemisia vulgaris L. extracts and the prospect of further pharmacological experiments. At the present stage of the development of science, it remains relevant to create new medicines of plant origin with the use of extracts as active substances and improvement of the composition and technology of existing ones. The article aimed to highlight the main stages of preclinical studies of herbal extracts of Artemisia species to establish their pharmacological activity, preclinical safety profile, and prospects for further research in developing a medicinal product. As a result of the research conducted using the method of generalization and systematic analysis, we identified the main stages of pharmacological research of plant extracts as medicinal substances using the example of Artemisia absinthium L. and Artemisia vulgaris L. extracts. Identifying the main stages of pharmacological research of plant extracts is necessary to establish the preclinical profile of the substance's safety, pharmacological effectiveness, and prospects for further study in the development of the medicinal product. In the first stage, a toxico-pharmacological study of the extracts is carried out, which includes the study of acute toxicity of the еxtracts. It was established that the intragastric administration of extracts of Artemisia absinthium L. and Artemisia vulgaris L. at a dose of 6000 mg/kg does not lead to the death of animals, which indicates the absence of toxic effects of the extracts in this dose, and characterizes them as practically non-toxic (toxicity class V, LD50 > 5000 mg/kg). At the second stage of pharmacological research, the anti-inflammatory activity of Artemisia absinthium L. and Artemisia vulgaris L. extracts was studied (on models of formalin, carrageenan, and zymosan edema). It was established that the sections of Artemisia absinthium L. and Artemisia vulgaris L. showed a pronounced anti-exudative effect throughout the experiment. At the third research stage, a study of specific pharmacological activity – hepatoprotective (antioxidant) training was activity. It was found that extracts of Artemisia species exhibit hepatoprotective activity in acute toxic liver damage, which leads to a decrease in the intensity of the lipid peroxidation process and a reduction in the harmful effect of tetrachloromethane, bringing the biochemical indicators of blood and liver homogenate of animals to the level of intact animals. The results of the research show that the extract of the herb Artemisia absinthium L. at a dose of 25 mg/kg of the animal's body weight showed a more intense and more effective effect in acute hepatitis compared to the extract of the herb Artemisia vulgaris L. The extract of the herb Artemisia...

29 March 2026 in Art of Medicine
Verified
Journal Article
Open access
PDF file
VHV.V. Holotyuk
V.V. Holotyuk
IHI.S. Holotyuk
I.S. Holotyuk
HHH.A. Hirna
H.A. Hirna
RHR.A. Hrytsyk
R.A. Hrytsyk
ZPZ.B. Popovych
Z.B. Popovych
The aim. The purpose of the study is aimed at creating and implementing an effective training program that meets the needs of modern medicine and will contribute to improving the qualifications of doctors in the field of diagnosing visual forms of cancer. Materials and methods. As part of the implementation of the competence approach, as the main principle of new educational standards, as well as the systematic development of clinical thinking among medical professionals, the Department of Oncology of the Ivano-Frankivsk National Medical University strives to ensure the development of practical skills, draw the attention of not only students, but also practicing doctors to the problem of oncological diseases visual localizations, familiarize with the achievements of leading domestic and foreign specialists in this field of medicine, teach how to use this knowledge in practice. In accordance with these requirements, the training program for the advanced training course, thematic improvement "Diagnostics of visual forms of cancer", lasting 78 hours, 2.4 ECTS credits, including both lectures and practical and seminar classes, was drawn up. In the goals and objectives of the educational discipline, the main emphasis is placed on deepening their theoretical knowledge and practical skills in the diagnosis of visual forms of cancer according to modern guidelines based on the existing level of knowledge and skills to improve professional skills. Results. In the advanced training course on diagnosing visual forms of cancer, a comprehensive educational program was implemented, lasting 78 hours and carrying 2.4 ECTS credits. The curriculum focused on theoretical knowledge and practical skills development, incorporating modern teaching methods such as lectures, seminars, and hands-on exercises with medical simulators. Participants acquired expertise in early diagnosis of various cancers, emphasizing risk factors and precancerous conditions for each type. Practical skills were honed through the use of tables, situational tasks, and diagnostic devices, fostering a clear understanding of the clinical route for patients with suspected visual cancer forms. The course extensively covered current health care legislation, norms, and statistics related to cancer incidence and mortality, particularly in the Ivano-Frankivsk region and Ukraine. Special emphasis was placed on recognizing of neglected cancers, contributing to a more comprehensive and proactive approach in addressing critical healthcare challenges. Educational discussions facilitated the exchange of experiences and opinions, fostering independent thinking and critical evaluation of information. The final stage required participants to demonstrate proficiency in clinical and physical examination methods, interpretation of laboratory results, and morphological verification of oncological diagnoses. The results underscore the program's efficacy in enhancing practical skills and knowledge among medical specialists. Conclusions. The conclusions of this study indicate the success of the program and indicate an increase in the level of professional skill of the participants, who have acquired the necessary knowledge and skills for effective work in the field of visual cancer diagnosis. The advanced training course "Diagnosis of visual forms of cancer" was developed taking into account modern guidelines and aimed at deepening the theoretical knowledge and practical skills of doctors. У статті обґрунтовано важливість формування мотивованих фахівців, які мають не лише теоретичні знання, але і навички роботи з інформацією та вміння самостійно вирішувати практичні завдання. Мета дослідження спрямована на створення та впровадження ефективної програми навчання, яка відповідає потребам сучасної медицини та сприятиме підвищенню кваліфікації лікарів у сфері діагностики візуальних форм раку. Матеріали та методи. Кафедра онкології Івано-Франківського національного медичного університету реалізує програму навчання "Діагностика візуальних форм раку", спрямовану на поглиблення теоретичних знань і практичних навичок у цій області. Навчальний курс включає лекції, практичні та семінарські заняття, зосереджуючись на сучасних методах діагностики і факторах ризику. Учасники навчання ознайомлюються з актуальним законодавством та статистикою захворюваності. Практичні навички відпрацьовуються на муляжах та тренажерах, а дискусії сприяють обміну досвідом і аналізу інформації. Після завершення курсу учасники повинні володіти клінічними та фізикальними методами обстеження хворих з візуальними формами раку. Результати дослідження. Дослідження показало, що освітня програма та курс навчання "Діагностика візуальних форм раку" ретельно розроблені для формування та поглиблення практичних навичок у фахівців медицини. Застосування сучасних...

29 March 2026 in Art of Medicine
Verified
Journal Article
Open access
PDF file
TTT. I. Teren
T. I. Teren
YPYu. D. Partykevych
Yu. D. Partykevych
RHR. A. Hrytsyk
R. A. Hrytsyk
The assessment of therapeutic pathomorphosis is a significant indicator for determining the effectiveness of preoperative treatment and improving the resectability of solid epithelial tumors localized in the colon. The study aimed to evaluate the efficacy of intravenous 5-fluorouracil administration combined with concurrent large-fraction irradiation of the tumor in a neoadjuvant regimen for patients with resectable colon cancer. Trusting the results of therapeutic pathomorphosis assessment, which is a reliable criterion for determining the effectiveness of chemoradiotherapy, certain conclusions can be drawn about the appropriateness of this combination of therapeutic methods. The use of a chemoradiotherapy component in the preoperative stage has specific impacts on the structure of the tumor site, causing multiple partial necroses in the tumor, as well as irreversible changes, facilitating ablastic surgical intervention, reducing the risk of local recurrence, and improving the resectability of the tumor process. Objective. To study the characteristics of therapeutic pathomorphosis induced by neoadjuvant chemoradiotherapy in patients with locally advanced colon cancer based at the Municipal Non-Profit Enterprise "Ivano-Frankivsk Regional Clinical Oncology Center". Materials and Methods. The observation group consisted of 90 patients with locally advanced colon cancer (LACC). Examination and basic treatment were conducted according to the Protocol for Providing Medical Care to Patients with LACC, approved by the Ministry of Health of Ukraine. Depending on the sequence of therapeutic methods, all patients were divided into the following groups: Group I included patients with locally advanced LACC who received a course of neoadjuvant chemoradiotherapy (NeoCRT) followed by surgical treatment (ST) and adjuvant chemotherapy (ACT) as indicated – 43 patients; Group II included patients with locally advanced LACC who underwent surgical treatment and ACT as indicated – 47 patients. Results. The comparison of morphological manifestations of therapeutic pathomorphosis with clinical data showed that the degree of their expression matched the objectively registered clinical effect, i.e., it was possible to judge the tumor's sensitivity to preoperative chemoradiotherapy based on morphological features. Thus, we noted significant dystrophic, necrobiotic, and necrotic changes in the tumor parenchyma under the influence of preoperative chemoradiation therapy, which indicates a decrease in tumor mass. In addition, the described disorders of blood circulation involve a slowdown in blood circulation, which probably leads to greater ablasticity of surgical intervention. Conclusions. Mandatory morphological examination of malignant colon tumors allowed summarizing the results of the analysis of their therapeutic pathomorphosis based on structural signs of tumor cell devitalization, including the presence of pathological mitoses, to determine the effectiveness of neoadjuvant (preoperative) methods of therapy for patients with locally advanced colon cancer. Neoadjuvant treatment of patients with locally advanced colon cancer by intravenous administration of 5-fluorouracil leads to multiple partial necroses of the tumor, and remote γ-irradiation results in subtotal and total irreversible changes in the tumor, ensuring ablastic radical surgical intervention. Оцінка лікувального патоморфозу є вагомим показником у цілому для визначення ефективності використаного лікування в доопераційному періоді та покращення резектабельності солідних пухлин епітеліального походження з локалізацією в ободовій кишці. Метою дослідження – вивчення ефективності внутрішньовенного введення 5-фторурацилу й одночасного крупнофракційного опромінення пухлини в неоад’ювантному режимі у хворих на резектабельний рак ободової кишки. Застосування хіміопроменевого компонента лікування на доопераційному етапі має певні впливи на структуру пухлинного осередку та викликає множинні парціальні некрози в пухлині, а також незворотні зміни в ній, що сприяє надалі абластичності проведення оперативного втручання, зменшує ризик місцевого рецидиву захворювання та покращує резектабельність пухлинного процесу. Мета. Вивчення особливостей лікувального патоморфозу, зумовленого неоад’ювантною хіміопроменевою терапією у хворих на місцево поширений рак ободової кишки на базі КНП «ПКОЦ ІФ ОР». Матеріали та методи. Групу спостережень становили 90 хворих на місцево поширений рак ободової кишки (РОК). Усі хворі розподілені на групи таким чином: І група – хворі на місцево поширений РОК, які отримували курс неоад’ювантної хіміопроменевої терапії (НеоАХПТ) з наступним хірургічним лікуванням (ХЛ) і ад’ювантною хіміотерапією (АХТ) за показами, – 43 пацієнти; ІІ група – хворі на місцево...

29 March 2026 in Art of Medicine
Verified
Journal Article
Open access
PDF file
SKS. V. Kostelei
S. V. Kostelei
OKO. V. Kysylytsia
O. V. Kysylytsia
IVI. V. Vytrykhovska
I. V. Vytrykhovska
IDI. T. Drin
I. T. Drin
RHR. A. Hrytsyk
R. A. Hrytsyk
IDI. B. Dyakiv
I. B. Dyakiv
Breast cancer (BC) ranks first among all malignant neoplasms in the female population. The World Health Organization’s International Agency for Research on Cancer (IARC) predicts that by 2050, more than 35 million new cases of cancer will be recorded (77% more than in 2022), and the number of fatalities will double to over 18 millions. In the structure of malignant neoplasms, polyneoplasia accounts for an average of 2.47%, and according to many authors, its share has been increasing in recent decades. Among women, the reproductive system is the most vulnerable to primary multiple malignant tumors. It shoud be mentioned that the most common combinations are hormone-dependent formations (breast cancer (BC), uterine cancer (UC), and ovarian cancer (OC)) with colorectal cancer (CRC) and gastric cancer (GC). Diseases of civilization, which have engulfed the planet over the past 15 years, have had a significant impact on this phenomenon. Objective of the study. To analyze cases of metachronous neoplasia in patients with breast cancer, including age structure, the timing of the second neoplasm occurrence, distribution by stage, and molecular subtype of BC. Materials and methods. A retrospective study of 73 patients with breast cancer who received comprehensive treatment at the KNP "Prykarpattia Clinical Oncology Center of the Ivano-Frankivsk Regional Council" from 2019 to 2023 was conducted. Only those patients who faced primary multiple malignant tumors were considered. Results. From 2019 to 2023, the structure of patients with primary multiple BC was dominated by those with metachronous EC, OC, CRC, or GC (44%). In patients with breast cancer, metachronous endometrial or colorectal cancer mostly occurred after 10 years (33.33% and 52.17%, respectively). Gastric cancer was most often diagnosed within one year (40%), and ovarian cancer within 5 years (50%). Women aged 50 to 59 years (working-age population) were usually affected by primary multiple breast cancer. Metachronous EC, OC, and CRC mostly occurred in patients with primary diagnosed stage IIA-IIB BC (54.17%, 58.33%, and 50%, respectively). Statistically significant data on metachronous GC have not yet been obtained. Endometrial, ovarian, and colorectal cancers are most often associated with hormone-dependent subtypes of breast cancer: EC and OC with luminal B (38.89% and 57.14%, respectively), and CRC with luminal A (44.45%). GC is equally associated with luminal B and Her2/neu-positive subtypes (50% each). Conclusions. Metachronous tumors of the uterus, ovary, colon, and stomach were mostly diagnosed in women aged 59-59, who belong to the working population. Based on our analysis we can consider that uterine and colon cancer more often occurred after 10 years, gastric cancer within one year and ovarian cancer within 5 years. The obtained results demonstrate the necessity for further study of the relationship between breast cancer and metachronous cancers of the uterus, ovary, colon, and stomach. More attention should be paid to genetic factors, the impact of hyperestrogenism, diabetes mellitus, obesity, and other concomitant nosologies. The acquired knowledge should be directed towards improving screening programs and early diagnosis for both breast cancer and polyneoplasia. Considering all key factors, an attempt should be made to develop an algorithm for calculating the risk of metachronous tumors in patients with primary-diagnosed breast cancer. Рак грудної залози (РГЗ) посідає перше місце серед усіх злоякісних новоутворень жіночого населення. Міжнародне агентство ВООЗ із дослідження раку (IARC) прогнозує до 2050 року значне збільшення захворюваності на рак і подвоєння летальних випадків. У структурах злоякісних новоутворень полінеоплазії займають у середньому 2,47%, і їхня частка продовжує зростати. Серед жінок найбільш уразливою до первинно-множинних злоякісних пухлин є репродуктивна система. Найчастіше спостерігаємо поєднання гормонально-залежних утворень (раку грудної залози (РГЗ), тіла матки (РТМ) і яйників (РЯ)) із раком товстої кишки (РТК) та шлунка (РШ)). Вагомий вплив на це явище мають хвороби цивілізації. Мета дослідження. Проаналізувати метахронні неоплазії в пацієнток на рак грудної залози. Матеріали і методи. Ретроспективно досліджено 73 пацієнтки з метахронними полінеоплазіями, які лікувалися в КНП “ПКОЦ ІФ ОР” із 2019 по 2023. Результати. У структурі пацієнток на первинно-множинний РГЗ переважали працездатні жінки (50-59 років) з метахронними РТМ, РЯ, РТК чи РШ (44%). Рак тіла матки й товстої кишки здебільшого діагностували через 10 років (33,33% і 52,17% відповідно), рак шлунка – упродовж року (40%), а рак яйника – за 5 років (50%). Згадані метахронні пухлини здебільшого виникали в пацієнток на первинно-діагностований РГЗ ІІА-ІІВ стадії. РТМ і РЯ найчастіше асоціюються з люмінальним В типом РГЗ (38,89% і 57,14%...